Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata

Status Not yet recruiting

Clinical Trial Summary

This is a prospective, randomized, open-label, controlled study, aiming to enroll 30 patients with Condylomata Acuminata. The study consists of two phases: a treatment phase (Weeks W1-W12) and an observation phase (Weeks W13-W24). Eligible patients will be randomly allocated into three groups at a ratio of 1:1:1: Test Group 1, Test Group 2, or the Control Group. And clinical cure, recurrence rates, adverse events, vital signs, laboratory tests, drug exposure doses, premature withdrawals will be analyzed.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Condylomata Acuminata

Clinical Trial Details

NCT number	NCT06430190
Study type	Interventional
Source	First People's Hospital of Hangzhou
Contact
Status	Not yet recruiting
Phase	N/A
Start date	July 2024
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04537156` - Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)	Phase 3
Completed	`NCT00090285` - An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)	Phase 3
Completed	`NCT00973856` - Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands	N/A
Completed	`NCT02015260` - A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts	Phase 2
Active, not recruiting	`NCT05056402` - An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old	Phase 3
Withdrawn	`NCT00365443` - Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)	Phase 2
Not yet recruiting	`NCT01483794` - Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile	N/A
Completed	`NCT03935204` - Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)	Phase 2
Completed	`NCT02405520` - Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine	Phase 1
Active, not recruiting	`NCT02710851` - Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine	Phase 2
Completed	`NCT04782895` - Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age	Phase 3
Completed	`NCT03546842` - Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)	Phase 3
Completed	`NCT03981822` - A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts	Phase 2
Recruiting	`NCT03158480` - Safety and Efficacy of Immune Therapy for Condyloma	N/A
Completed	`NCT01598779` - Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population	N/A
Completed	`NCT00449982` - Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts	Phase 3
Completed	`NCT03813940` - Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)	Phase 1
Not yet recruiting	`NCT06197802` - Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women
Completed	`NCT01532102` - Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts	Phase 1/Phase 2
Active, not recruiting	`NCT06297187` - Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study